Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus subcutaneous dexamethasone for prevention of pain after cesarean section
IRCT20220430054707N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of dexamethasone in postoperative pain (3 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Postoperative pain and Neonatal Apgar score. Started Sep 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20220430054707N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220430054707N1.